(Q45729115)

English

High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors

scientific article published in February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

vector-borne disease

0 references

0 references

1 reference

based on heuristic

inferred from title

Epstein–Barr virus

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Henri-Jacques Delecluse

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Clemens-Martin Wendtner

1

object named as

Clemens-Martin Wendtner

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

9

object named as

Michael Hallek

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Christian Kurzeder

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hans D Theiss

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

David M Kofler

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Jens Baumert

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Annette Janz

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Wolfgang Hammerschmidt

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Experimental Hematology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

99-108

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

New aspects on the pathogenesis, diagnostic procedures, and therapeutic management of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired CD40-ligand deficiency in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic lymphocytic leukemia B cells are highly sensitive to infection by herpes simplex virus-1 via herpesvirus-entry-mediator A.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro infection of chronic lymphocytic leukemia cells by Epstein-Barr virus (EBV).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation and immortalization of leukaemic B cells by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

EBV infection of B-CLL cells in vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

LMP-1, the Epstein-Barr virus-encoded oncogene with a B cell activating mechanism similar to CD40.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein barr virus (EBV)‐carrying cells of a chronic lymphocytic leukemia (CLL) subpopulation express EBNA1 and LMPS but not EBNA2 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A first-generation packaging cell line for Epstein-Barr virus-derived vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Adeno-associated virus vectors preferentially transduce cells in S phase.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tap-1 and Tap-2 Gene Therapy Selectively Restores Conformationally Dependent HLA Class I Expression in Type I Diabetic Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The Epstein-Barr virus and its association with human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus infection in Richter's transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901019-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0301-472X(02)01019-6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45729115&oldid=2078986859"